POINT Biopharma Global Inc. (NASDAQ:PNT) Receives $12.88 Consensus Price Target from Analysts
POINT Biopharma Global Inc. (NASDAQ:PNT – Get Free Report) has been given a consensus rating of “Hold” by the ten brokerages that are covering the stock, MarketBeat Ratings reports. Ten analysts have rated the stock with a hold recommendation. The average 1-year price objective among analysts that have issued a report on the stock in […]
More Stories
Elevated Capital Advisors LLC Has $376,000 Holdings in iShares MSCI USA Momentum Factor ETF (BATS:MTUM)
Elevated Capital Advisors LLC decreased its holdings in shares of iShares MSCI USA Momentum Factor ETF (BATS:MTUM – Free Report)...
Elevated Capital Advisors LLC Has $616,000 Holdings in Newell Brands Inc. (NASDAQ:NWL)
Elevated Capital Advisors LLC decreased its holdings in Newell Brands Inc. (NASDAQ:NWL – Free Report) by 12.9% during the 4th...
280 Shares in Digital Realty Trust, Inc. (NYSE:DLR) Purchased by Friedenthal Financial
Friedenthal Financial acquired a new stake in shares of Digital Realty Trust, Inc. (NYSE:DLR – Free Report) in the 4th...
6,435 Shares in Tri Pointe Homes, Inc. (NYSE:TPH) Purchased by Elevated Capital Advisors LLC
Elevated Capital Advisors LLC bought a new position in shares of Tri Pointe Homes, Inc. (NYSE:TPH – Free Report) during...
Bar Harbor Wealth Management Reduces Position in iShares National Muni Bond ETF (NYSEARCA:MUB)
Bar Harbor Wealth Management trimmed its position in shares of iShares National Muni Bond ETF (NYSEARCA:MUB – Free Report) by...
Vanguard FTSE Emerging Markets ETF (NYSEARCA:VWO) Shares Sold by Eastern Bank
Eastern Bank lowered its position in shares of Vanguard FTSE Emerging Markets ETF (NYSEARCA:VWO – Free Report) by 9.6% during...